{"podcast":{"title":"Galaxy Balance","slug":"galaxy-balance-7619530","podcast_index_feed_id":7619530,"rss_url":"https://api.riverside.fm/hosting/TsNBRv3G.rss","website_url":"https://www.youtube.com/@GalaxyBalance","image_url":"https://hosting-media.riverside.com/media/podcasts/c0a4b47b-b2c9-4c68-88b5-1baa3a352c83/logos/0081482a-5241-4cdc-aa4f-c89d3aca95e7.png","author":"Cory Smith","episode_count":28,"summary":"Galaxy Balance explores the frontier where biology, technology and consciousness meet. Each episode brings together pioneers shaping our collective future, from genome engineers and AI builders to longevity researchers, space explorers, and mindfulness practitioners. Hosted by Cory Smith, the conversations dive deep into how these seemingly distant fields form an interconnected ecosystem, one that balance innovation with introspection, science with spirit, and ambition with awareness. At its core, Galaxy Balance is about integration; the idea that our greatest leaps forward happen when disciplines collide. The same algorithms that decode galaxies can help us understand genomes; the same principles that govern consciousness can illuminate AI. Through long-form, unscripted dialogue, the show invites listeners to zoom out from the silos of specialization and see the larger pattern: a living system of intelligence evolving across scales – molecular, planetary, and cosmic.","last_synced_at":"2026-09-24T00:19:02.360701+00:00","page_url":"https://stenobird.com/podcast/galaxy-balance-7619530"},"episode":{"title":"Can We Make a Drug for One Person?","slug":"can-we-make-a-drug-for-one-person","published_at":"2026-08-24T20:30:00+00:00","page_url":"https://stenobird.com/podcast/galaxy-balance-7619530/can-we-make-a-drug-for-one-person","show_page_url":"https://stenobird.com/podcast/galaxy-balance-7619530","url":"https://api.riverside.com/hosting-analytics/media/ccc319887a8217a541d9be5a5d30dafeb774cbe759d2e0a34e11f482fd0daa98/eyJlcGlzb2RlSWQiOiI4MTE1NWFhYi00ZGFlLTQ5MDktODhkNS0yODdhYmJkNTNmNzEiLCJwb2RjYXN0SWQiOiJjMGE0YjQ3Yi1iMmM5LTRjNjgtODhiNS0xYmFhM2EzNTJjODMiLCJhY2NvdW50SWQiOiI2OTBiYjRiMzM2NjY3MWFlZGQwZTZhMTEiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmE4YzI5NTFmMjY5Y2ZkMTVmNTYwY2Y1L2Nvcnktc21pdGhzLXN0dWRpby1sTktuWC1jb21wb3Nlci0yMDI2LTgtMjRfXzEzLTIxLTUyLm1wMyJ9.mp3","audio_url":"https://api.riverside.com/hosting-analytics/media/ccc319887a8217a541d9be5a5d30dafeb774cbe759d2e0a34e11f482fd0daa98/eyJlcGlzb2RlSWQiOiI4MTE1NWFhYi00ZGFlLTQ5MDktODhkNS0yODdhYmJkNTNmNzEiLCJwb2RjYXN0SWQiOiJjMGE0YjQ3Yi1iMmM5LTRjNjgtODhiNS0xYmFhM2EzNTJjODMiLCJhY2NvdW50SWQiOiI2OTBiYjRiMzM2NjY3MWFlZGQwZTZhMTEiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmE4YzI5NTFmMjY5Y2ZkMTVmNTYwY2Y1L2Nvcnktc21pdGhzLXN0dWRpby1sTktuWC1jb21wb3Nlci0yMDI2LTgtMjRfXzEzLTIxLTUyLm1wMyJ9.mp3","summary":"What if we could design a medicine for a single person? Casey McPherson was a musician and songwriter when his daughter Rose was diagnosed with an ultra-rare neurogenetic disease. There was no approved treatment and no clear path forward. Rather than accepting that answer, Casey began learning genetics, building a network of scientists, and ultimately creating the infrastructure needed to develop a treatment for his daughter. Today, Casey is the CEO and co-founder of Alpha Rose Therapeutics, where his team is working to make individualized genetic medicine scalable. Their approach combines antisense oligonucleotides, patient-derived stem cells, AI-guided therapeutic design, automation, and a new economic model for diseases that traditional drug development often leaves behind. We discuss how Alpha Rose reduced a therapeutic amenability analysis that once took months to just minutes using AI, why Casey believes drug development should eventually be approved as a repeatable process rather than one drug at a time, and how point-of-care synthesis could allow personalized genetic medicines to be produced rapidly for individual patients. We also explore autonomous laboratories, AI scientists, patient-derived iPSCs and brain organoids, the economics of rare disease, genetic enhancement, and a future of medicine that looks increasingly like the sick bay of Star Trek: understand the unique biology of the patient, design the intervention, synthesize it, and treat them. Casey's story raises a much bigger question. Are rare diseases really rare, or are they the first glimpse of a future where every disease becomes individualized? 00:00 - Casey McPherson’s path from musician to biotech founder 01:38 - Childhood curiosity: music, programming, electronics, and biology 04:16 - Rose’s…","meta_description":"What if we could design a medicine for a single person? Casey McPherson was a musician and songwriter when his daughter Rose was diagnosed with an ultra-r…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3820,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/galaxy-balance-7619530/episodes/can-we-make-a-drug-for-one-person/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/galaxy-balance-7619530/can-we-make-a-drug-for-one-person.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}